The latest newly defined tissue-resident memory T cells (TRMs), whose main surface markers are CD103, CD69 and CD49a, are classified as a cluster of memory T cells different from central memory T cells and effector memory T cells, and this population persists in tumor tissues and no longer participates in T cell recirculation (44–47). The gene discussed is CD69; the disease is neoplasm.